(Q35743115)

10 August 2017

1 reference

title

PML nuclear bodies and apoptosis (English)

1 reference

Valérie Lallemand-Breitenbach

10 August 2017

1 reference

4

Hugues de Thé

0 references

series ordinal

2

object named as

Valérie Lallemand-Breitenbach

1 reference

10 August 2017

Yuki Takahashi

1

1 reference

10 August 2017

Jun Zhu

series ordinal

3

1 reference

10 August 2017

language of work or name

English

0 references

publication date

1 April 2004

1 reference

10 August 2017

1 reference

10 August 2017

23

1 reference

10 August 2017

2819-2824

1 reference

10 August 2017

16

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.onc.1207533

10 August 2017

0 references

cites work

The interaction of Pax5 (BSAP) with Daxx can result in transcriptional activation in B cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207533

The homeodomain-interacting kinase PKM (HIPK-2) modifies ND10 through both its kinase domain and a SUMO-1 interaction motif and alters the posttranslational modification of PML.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207533

PML is critical for ND10 formation and recruits the PML-interacting protein daxx to this nuclear structure when modified by SUMO-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207533

Modification of Daxx by small ubiquitin-related modifier-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207533

p14ARF induces the relocation of HDM2 and p53 to extranucleolar sites that are targeted by PML bodies and proteasomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207533

Identification and characterization of HIPK2 interacting with p73 and modulating functions of the p53 family in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207533

Cellular stress and DNA damage invoke temporally distinct Mdm2, p53 and PML complexes and damage-specific nuclear relocalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207533

Role of promyelocytic leukemia (PML) sumolation in nuclear body formation, 11S proteasome recruitment, and As2O3-induced PML or PML/retinoic acid receptor alpha degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207533

The promyelocytic leukemia protein protects p53 from Mdm2-mediated inhibition and degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207533

Nuclear domain 10 (ND10) associated proteins are also present in nuclear bodies and redistribute to hundreds of nuclear sites after stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207533

Activation of p53 by protein inhibitor of activated Stat1 (PIAS1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207533

Covalent modification of p73alpha by SUMO-1. Two-hybrid screening with p73 identifies novel SUMO-1-interacting proteins and a SUMO-1 interaction motif

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207533

Proteasome inhibitor induces nucleolar translocation of Epstein-Barr virus-encoded EBNA-5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207533

Members of the PIAS family act as SUMO ligases for c-Jun and p53 and repress p53 activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207533

Cutting edge: tyk2 is required for the induction and nuclear translocation of Daxx which regulates IFN-alpha-induced suppression of B lymphocyte formation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207533

The nuclear dot protein sp100, characterization of domains necessary for dimerization, subcellular localization, and modification by small ubiquitin-like modifiers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207533

Physical and functional interactions between PML and MDM2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207533

MDM2 and Promyelocytic Leukemia Antagonize Each Other through Their Direct Interaction with p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207533

How acute promyelocytic leukaemia revived arsenic

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207533

Arsenic-induced PML targeting onto nuclear bodies: implications for the treatment of acute promyelocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207533

The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor alpha gene to a novel transcribed locus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207533

7 January 2021

The PML-RARα fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207533

7 January 2021

A comparison of the activity, sequence specificity, and CRM1-dependence of different nuclear export signals

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207533

7 January 2021

PML protein isoforms and the RBCC/TRIM motif

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207533

7 January 2021

Regulation of Pax3 transcriptional activity by SUMO-1-modified PML

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207533

7 January 2021

Sequestration and inhibition of Daxx-mediated transcriptional repression by PML

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207533

7 January 2021

Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207533

7 January 2021

EAP1/Daxx interacts with ETS1 and represses transcriptional activation of ETS1 target genes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207533

7 January 2021

Human fibroblasts require the Rb family of tumor suppressors, but not p53, for PML-induced senescence.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207533

7 January 2021

RNAi reveals anti-apoptotic and transcriptionally repressive activities of DAXX

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207533

7 January 2021

Cellular proteins localized at and interacting within ND10/PML nuclear bodies/PODs suggest functions of a nuclear depot

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207533

7 January 2021

PML interaction with p53 and its role in apoptosis and replicative senescence

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207533

7 January 2021

PML regulates p53 acetylation and premature senescence induced by oncogenic Ras

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207533

7 January 2021

Leukemia-associated translocation products able to activate RAS modify PML and render cells sensitive to arsenic-induced apoptosis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207533

7 January 2021

Role and fate of PML nuclear bodies in response to interferon and viral infections

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207533

7 January 2021

The role of PML in tumor suppression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207533

7 January 2021

SUMO: of branched proteins and nuclear bodies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207533

7 January 2021

PML is essential for multiple apoptotic pathways

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207533

7 January 2021

Acute promyelocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207533

7 January 2021

Promyelocytic leukemia protein (PML) and Daxx participate in a novel nuclear pathway for apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207533

7 January 2021

P14ARF promotes accumulation of SUMO-1 conjugated (H)Mdm2.

1 reference

2 April 2022

https://opencitations.net/index/coci/api/v1/citations/10.1016/S0014-5793(02)03310-0

Identifiers

DOI

10.1038/SJ.ONC.1207533

1 reference

Dimensions Publication ID

10 August 2017

0 references

1 reference